Study Protocol from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial

MLA

Benjamin Besse, et al. Study Protocol from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial. Apr. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22700533.v1.

APA

Benjamin Besse, Jean-Charles Soria, Marta Jimenez, Filippo Gustavo Dall’Olio, Alexandra Jacquet, Alicia Tran-Dien, Alain Morel, Isabelle Soubeyran, Valery Attignon, Sandrine Boyault, Ludovic Lacroix, Ivan Bieche, Etienne Giroux-Leprieur, Nicolas Cloarec, Pierre-Jean Souquet, François Chomy, Josiane Otto, Alexis Cortot, Eric Pichon, … Fabrice Barlesi. (2023). Study Protocol from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial. https://doi.org/10.1158/1078-0432.22700533.v1

Chicago

Benjamin Besse, Jean-Charles Soria, Marta Jimenez, Filippo Gustavo Dall’Olio, Alexandra Jacquet, Alicia Tran-Dien, Alain Morel, et al. 2023. “Study Protocol from Comprehensive Genome Profiling in Patients With Metastatic Non–Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial,” April. doi:10.1158/1078-0432.22700533.v1.